Home › Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT (vintafolide) and Companion Imaging Agents FOLCEPRI (etarfolatide) and NEOCEPRI (Intravenous (IV) folic acid) in Patients with Platinum-Resistant ...
 

Keywords :   


Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT (vintafolide) and Companion Imaging Agents FOLCEPRI (etarfolatide) and NEOCEPRI (Intravenous (IV) folic acid) in Patients with Platinum-Resistant ...

2014-03-21 13:05:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. & WEST LAFAYETTE, Ind. WHITEHOUSE STATION, N.J. & WEST LAFAYETTE, Ind.--(BUSINESS WIRE)-- Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT (vintafolide) and Companion Imaging Agents FOLCEPRI (etarfolatide) and NEOCEPRI (Intravenous (IV) folic acid) in Patients with Platinum-Resistant Ovarian Cancer Language: English Contact: MerckMedia:Ian McConnell, +1 908-423-3046Claire Mulhearn, +1 908-423-7425orInvestors:Carol Ferguson, +1 908-423-4465Justin Holko, +1 908-423-5088orEndocyteMedia:Martina Schwarzkopf, +1 212-845-4292Tony Russo, +1 212-845-4251orInvestors:Stephanie Ascher, +1 212-362-1200 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: ECYT Exchange: NASDAQ read more

Tags: in with positive opinions

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
More »